Saturday, January 28, 2023 | Back issues
Courthouse News Service Courthouse News Service

Courthouse News Top Download

Shareholders accuse Ligand Pharmaceuticals of overstating its assets and exaggerating its financial picture, causing its share price to plummet 5 percent in just two days once the problems came out.

SAN DIEGO - Shareholders accuse Ligand Pharmaceuticals of overstating its assets and exaggerating its financial picture, causing its share price to plummet 5 percent in just two days once the problems came out.

USDC Southern District of California

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...